This webinar, in collaboration with the Biochemical Society's Clinical Science journal, celebrated twenty years of ACE2.

Twenty years after its discovery, angiotensin-converting enzyme 2 (ACE2) has become one of the most studied proteins. Since ACE2 was identified as the SARS-coronavirus 2 receptor, it has held centre stage with already more than 500 peer-reviewed publications in 2020. This webinar is related to the themed collection published by Clinical Science titled ‘ACE2, a multifunctional protein – from cardiovascular regulation to COVID-19’ which features reviews and original papers on the physiological and pathophysiological roles of the multiple known tasks of ACE2 including carboxypeptidase, amino acid transport regulator, and virus receptor functions.

Invited Speakers:

• Professor Anthony Turner, University of Leeds, UK
• Professor Rhian Touyz, University of Glasgow, UK
• Professor Michael Bader, Max Delbruck Institute, Germany

This webinar was chaired by Professor Rhian Touyz, Director of the Institute of Cardiovascular & Medical Sciences and British Heart Foundation Chair of Cardiovascular Medicine at the University of Glasgow.